Zota Health Care Ltd
Zota Health Care Ltd Share Price Today: Live Updates & Key Insights
Get insights on Zota Health Care Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Zota Health Care Ltd Share Price Chart
Zota Health Care Ltd Fundamentals
Traded Volume: 31,367
Market Cap(Cr): 4,657
Avg Traded Price 353.48
1 Year return 150.40%
Upper Circuit 1,544
Lower Circuit 1,502.5
P/E TTM -76.00
P/B Ratio -20.00
Traded Value(Cr) 481.55
EPS TTM -20.116
Book value -20.116
Dividend 0.00%
Zota Health Care Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Zota Health Care Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Zota Health Care Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -1.04%
1M -0.31%
3M +28.62%
1Y +150.40%
YTD +91.76%
Zota Health Care Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Zota Health Care Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 54587.00
Day Before Yesterday 48071.00
1W Avg 55658.00
1M Avg 83508.95
3M Avg 89153.21
Zota Health Care Ltd Technical Details
Zota Health Care Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 1510
Support 2 1486
Support 3 1469
Pivot Point : 1527
Resistance 1 1552
Resistance 2 1569
Resistance 3 1593
Zota Health Care Ltd Corporate Actions
Zota Health Care Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Zota Health Care Ltd’s capital allocation strategies.
All
Ex-Date 22-Sep-2025 Type D Description 1.00/share@10.00% Record Date 22-Sep-2025 Ratio 10.00
Ex-Date 20-Sep-2024 Type D Description 1.00/share@10.00% Record Date 21-Sep-2024 Ratio 10.00
Ex-Date 22-Sep-2023 Type D Description 1.00/share@10.00% Record Date 07-Nov-2025 Ratio 10.00
Ex-Date 19-Sep-2022 Type D Description 1.50/share@15.00% Record Date 07-Nov-2025 Ratio 15.00
Ex-Date 22-Sep-2021 Type D Description 1.00/share@10.00% Record Date 07-Nov-2025 Ratio 10.00
Ex-Date 17-Sep-2020 Type D Description 1.00/share@10.00% Record Date 07-Nov-2025 Ratio 10.00
Ex-Date 12-Sep-2019 Type D Description 1.00/share@10.00% Record Date 07-Nov-2025 Ratio 10.00
Ex-Date 25-Jul-2019 Type B Description share@4:10 Record Date 26-Jul-2019 Ratio 4:10
Ex-Date 02-Aug-2018 Type D Description 3.00/share@30.00% Record Date 07-Nov-2025 Ratio 30.00
Dividends
Announcement Date 22-Sep-2025 Ex Dividend Date 22-Sep-2025 Dividend(%) 10
Announcement Date 20-Sep-2024 Ex Dividend Date 20-Sep-2024 Dividend(%) 10
Announcement Date 22-Sep-2023 Ex Dividend Date 22-Sep-2023 Dividend(%) 10
Announcement Date 19-Sep-2022 Ex Dividend Date 19-Sep-2022 Dividend(%) 15
Announcement Date 22-Sep-2021 Ex Dividend Date 22-Sep-2021 Dividend(%) 10
Announcement Date 17-Sep-2020 Ex Dividend Date 17-Sep-2020 Dividend(%) 10
Announcement Date 12-Sep-2019 Ex Dividend Date 12-Sep-2019 Dividend(%) 10
Announcement Date 02-Aug-2018 Ex Dividend Date 02-Aug-2018 Dividend(%) 30
Bonus
Record Date 26-Jul-2019 Ex-Bonus Date 25-Jul-2019 Ratio 4:10
Splits
No Split has been declared by ZOTA
Others
Rights No Rights has been declared by ZOTA
Zota Health Care Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Zota Health Care Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Zota Health Care Ltd's relative performance and valuation against major competitors.
Stock Name Supriya Lifescience Ltd ₹788.85 (+1.23%) M. Cap (Cr) 63.49 1 Yr Return (%) +17.12% P/E (TTM) 35.65 PB Ratio 7.01
Stock Name Sequent Scientific Ltd ₹214.79 (-0.76%) M. Cap (Cr) 54.08 1 Yr Return (%) -3.08% P/E (TTM) 148.36 PB Ratio 7.95
Stock Name Gujarat Themis Biosyn Ltd ₹450.20 (+0.18%) M. Cap (Cr) 49.06 1 Yr Return (%) +35.44% P/E (TTM) 110.01 PB Ratio 21.96
Stock Name Zota Health Care Ltd ₹1535.20 (+0.44%) M. Cap (Cr) 46.57 1 Yr Return (%) +150.40% P/E (TTM) -76.32 PB Ratio 29.07
Stock Name Aarti Drugs Ltd ₹491.45 (+0.52%) M. Cap (Cr) 45.18 1 Yr Return (%) -0.57% P/E (TTM) 22.53 PB Ratio 3.51
Stock Name Innova Captab Ltd ₹767.50 (-4.42%) M. Cap (Cr) 43.92 1 Yr Return (%) -8.92% P/E (TTM) 35.29 PB Ratio 4.58
Stock Name Sun Pharma Advanced Research Company Ltd ₹133.35 (-0.91%) M. Cap (Cr) 43.28 1 Yr Return (%) -37.87% P/E (TTM) -14.50 PB Ratio -55.93
Zota Health Care Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Zota Health Care Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 -22.21 Mar 2024 -30.14 Mar 2023 -10.29 Mar 2022 13.66 Mar 2021 -0.84
PARTICULARS Investing Activities Mar 2025 -147.85 Mar 2024 -8.67 Mar 2023 12.76 Mar 2022 -27.06 Mar 2021 3.91
PARTICULARS Financing Activities Mar 2025 171.27 Mar 2024 38.08 Mar 2023 -3.79 Mar 2022 14.27 Mar 2021 -2.47
PARTICULARS Net Cash Flow Mar 2025 1.21 Mar 2024 -0.73 Mar 2023 -1.32 Mar 2022 0.87 Mar 2021 0.60
Zota Health Care Ltd Shareholding Pattern
This shows the ownership breakdown of Zota Health Care Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 55.81%
Public 35.51%
Other Institutions 4.89%
FII 3.49%
Mutual Funds 0.06%
About Zota Health Care Ltd
Zota Health Care Limited is a renowned pharmaceutical company that manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over-the-counter (OTC) products. The Company was incorporated in July 12, 2000 and is based out of Surat, Gujarat. The Company meets the requirements of millions of people by increasing access to high-quality, affordable medicines for chronic illnesses including heart disease, diabetes, thyroid disease, and others, giving India's pharmaceutical industry a boost.The Company has three business verticals: Marketing-a traditional business vertical, and driving business verticals - Exports and Retail harmacy Chain. Through its chain, Davaindia, the largest private-sector generic pharmacy chain, the Company is making strong inroads into the generic retail pharmacy business. The Company's state-of-the-art manufacturing facility at Sachin SEZ serves customers in more than 30 countries. Davaindia is a retail generic pharmacy chain whose core value proposition is providing quality generic medicines at substantial discounts, i.e. 30% to 90%, to their branded equivalents. Davaindia focuses on private-label products in the medicinal, OTC, and ayurvedic categories, with a greater emphasis on chronic therapies and ailments.The Marketing business vertical involves the direct distribution of generic drugs, OTC products, and other pharmaceutical products through the Company's distribution network across India. In domestic Marketing business, the Company procures finished dosage forms (FDFs) from domestic formulation manufactures and then market them under its portfolio of brands. It has a set of manufacturing partners recognized by the WHO with a rigorous focus on product quality. With a portfolio of more than 3000 products in various categories, such as generics, OTC products, allopathic, ayurvedic, etcetera, the Company cater to a variety of ailments. Currently, the Company has over 1050 distributors spread around the country. Instead of the Company directly engaging in sales, distribution, and promotion activities, its distributors engage in ethical marketing or other sales, distribution, and promotion activities on their own. Instead, it provide distributors directly with incentives to help them sell products more effectively.Secondly, the exports business vertical started in 2010, following the establishment of formulations manufacturing facility in the Sachin SEZ. The Company is required to export products from this unit in accordance with the laws governing this SEZ. At present, it has product approvals in 30 countries, particularly in the semi-regulated and regulated markets in the African, Asian, CIS, and Latin American countries. In this facility, the Company make around 250 formulations for direct exports and contract manufacturing. . At present, the Company has 253 dossiers approved across multiple countries, and another 311 dossiers have been filed and are pending approval. It significantly increased efforts and investments towards product registration, the results of which are now apparent in the form of product approvals and expansion of export operations. In the Retail Pharmacy Chain business vertical, the Company operates a chain of pharmacy stores under the brand - Davaindia. Davaindia focuses only on private-label products in the medicinal, OTC, and ayurvedic categories, with a greater emphasis on chronic therapies and ailments. This concept started with three pilot stores in 2017 and has been scaled up to become the largest private-sector generic pharmacy chain with more than 591 stores as of March 2021. Davaindia operates on a unique asset-light franchise model for majority stores. These stores are engaged in exclusive sales of Davaindia products, with more than 95% of products being private-label. In all areas and media, such as TV commercials, printing, digital & social media, radio, among others, the Company has undertaken bold and aggressive marketing and promotion activities with the firm intention of creating top-of-the-mind brand recall for Davaindia. Davaindia - being a front-runner in private sector generic pharmacy assumed the responsibility to create awareness, propagate virtues and debunk misconceptions about generic drugs. The Company launched the initial public offer of 46,80,000 equity shares of face value of Rs 10 each, by raising capital of Rs 58.5 Crore , comprising a fresh issue of 31,80,000 equity shares amounting to Rs 39.75 Cr and the offer for sale of 3,60,000 equity shares amounting to Rs 18.75 Cr in May, 2017.In 2019, the Company opened ~150 Davaindia outlets. Davaindia expanded to over 250 outlets, becoming the fastest-growing privatesector generic pharmacy chain in India in 2020. The Company acquired a 56% stake in Everyday Herbal Group, licensed by the Khadi and Village Industries Commission of India in May, 2024. The Davaindia footprint expanded the count to 1,582 operational stores in 2025.
Chairman & Non Executive Director
Ketankumar Zota
Registered office Zota House 2/896 Hira Modi St, Sagrampura, Surat, Gujarat, 395002
FAX :91-261-2331601
Background
Incorporation Year 2000
Face Value ₹10.00
Market Lot 1
FAQs on Zota Health Care Ltd
How to buy Zota Health Care Ltd shares on NSE?
To buy Zota Health Care Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Zota Health Care Ltd share price today?
The Zota Health Care Ltd share price on NSE is ₹1535.20 today.
What is the market cap of Zota Health Care Ltd on NSE?
The company has a market capitalization of ₹4656.67.
What is the PE & PB ratio of Zota Health Care Ltd?
PE is -76 and PB is -20.
What is the 52 Week High and Low of Zota Health Care Ltd shares?
Zota Health Care Ltd stock price high: ₹1627.70 Zota Health Care Ltd stock price low: ₹535.